These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

513 related articles for article (PubMed ID: 9501208)

  • 1. Bridging of beta-catenin and glycogen synthase kinase-3beta by axin and inhibition of beta-catenin-mediated transcription.
    Sakanaka C; Weiss JB; Williams LT
    Proc Natl Acad Sci U S A; 1998 Mar; 95(6):3020-3. PubMed ID: 9501208
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Suppression of glycogen synthase kinase activity is not sufficient for leukemia enhancer factor-1 activation.
    Yuan H; Mao J; Li L; Wu D
    J Biol Chem; 1999 Oct; 274(43):30419-23. PubMed ID: 10521419
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of AXIN2 expression by beta-catenin-T cell factor. A feedback repressor pathway regulating Wnt signaling.
    Leung JY; Kolligs FT; Wu R; Zhai Y; Kuick R; Hanash S; Cho KR; Fearon ER
    J Biol Chem; 2002 Jun; 277(24):21657-65. PubMed ID: 11940574
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Axin, an inhibitor of the Wnt signalling pathway, interacts with beta-catenin, GSK-3beta and APC and reduces the beta-catenin level.
    Nakamura T; Hamada F; Ishidate T; Anai K; Kawahara K; Toyoshima K; Akiyama T
    Genes Cells; 1998 Jun; 3(6):395-403. PubMed ID: 9734785
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Domains of axin involved in protein-protein interactions, Wnt pathway inhibition, and intracellular localization.
    Fagotto F; Jho Eh; Zeng L; Kurth T; Joos T; Kaufmann C; Costantini F
    J Cell Biol; 1999 May; 145(4):741-56. PubMed ID: 10330403
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of a Wnt/beta-catenin signaling pathway in human thyroid cells.
    Helmbrecht K; Kispert A; von Wasielewski R; Brabant G
    Endocrinology; 2001 Dec; 142(12):5261-6. PubMed ID: 11713224
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Signaling through beta-catenin and Lef/Tcf.
    Novak A; Dedhar S
    Cell Mol Life Sci; 1999 Oct; 56(5-6):523-37. PubMed ID: 11212302
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of glycogen synthase kinase 3beta and downstream Wnt signaling by axin.
    Hedgepeth CM; Deardorff MA; Rankin K; Klein PS
    Mol Cell Biol; 1999 Oct; 19(10):7147-57. PubMed ID: 10490650
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New steps in the Wnt/beta-catenin signal transduction pathway.
    Sakanaka C; Sun TQ; Williams LT
    Recent Prog Horm Res; 2000; 55():225-36. PubMed ID: 11036939
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modulation of Wnt signaling by Axin and Axil.
    Kikuchi A
    Cytokine Growth Factor Rev; 1999; 10(3-4):255-65. PubMed ID: 10647780
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Wnt-induced dephosphorylation of axin releases beta-catenin from the axin complex.
    Willert K; Shibamoto S; Nusse R
    Genes Dev; 1999 Jul; 13(14):1768-73. PubMed ID: 10421629
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tcf-1-mediated transcription in T lymphocytes: differential role for glycogen synthase kinase-3 in fibroblasts and T cells.
    Staal FJ; Burgering BM; van de Wetering M; Clevers HC
    Int Immunol; 1999 Mar; 11(3):317-23. PubMed ID: 10221643
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A GSK3beta phosphorylation site in axin modulates interaction with beta-catenin and Tcf-mediated gene expression.
    Jho Eh; Lomvardas S; Costantini F
    Biochem Biophys Res Commun; 1999 Dec; 266(1):28-35. PubMed ID: 10581160
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Axin, a negative regulator of the Wnt signaling pathway, forms a complex with GSK-3beta and beta-catenin and promotes GSK-3beta-dependent phosphorylation of beta-catenin.
    Ikeda S; Kishida S; Yamamoto H; Murai H; Koyama S; Kikuchi A
    EMBO J; 1998 Mar; 17(5):1371-84. PubMed ID: 9482734
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Axin prevents Wnt-3a-induced accumulation of beta-catenin.
    Kishida M; Koyama S; Kishida S; Matsubara K; Nakashima S; Higano K; Takada R; Takada S; Kikuchi A
    Oncogene; 1999 Jan; 18(4):979-85. PubMed ID: 10023673
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Axin and Frat1 interact with dvl and GSK, bridging Dvl to GSK in Wnt-mediated regulation of LEF-1.
    Li L; Yuan H; Weaver CD; Mao J; Farr GH; Sussman DJ; Jonkers J; Kimelman D; Wu D
    EMBO J; 1999 Aug; 18(15):4233-40. PubMed ID: 10428961
    [TBL] [Abstract][Full Text] [Related]  

  • 17. GSK-3beta-dependent phosphorylation of adenomatous polyposis coli gene product can be modulated by beta-catenin and protein phosphatase 2A complexed with Axin.
    Ikeda S; Kishida M; Matsuura Y; Usui H; Kikuchi A
    Oncogene; 2000 Jan; 19(4):537-45. PubMed ID: 10698523
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Downregulation of beta-catenin by human Axin and its association with the APC tumor suppressor, beta-catenin and GSK3 beta.
    Hart MJ; de los Santos R; Albert IN; Rubinfeld B; Polakis P
    Curr Biol; 1998 May; 8(10):573-81. PubMed ID: 9601641
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interaction among GSK-3, GBP, axin, and APC in Xenopus axis specification.
    Farr GH; Ferkey DM; Yost C; Pierce SB; Weaver C; Kimelman D
    J Cell Biol; 2000 Feb; 148(4):691-702. PubMed ID: 10684251
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of Wnt signaling pathway by a novel axin-binding protein.
    Kadoya T; Kishida S; Fukui A; Hinoi T; Michiue T; Asashima M; Kikuchi A
    J Biol Chem; 2000 Nov; 275(47):37030-7. PubMed ID: 10944533
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.